The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems

被引：0
|
作者：
Tricklebank, MD [1 ]
机构：
[1] MERCK SHARP & DOHME RES LABS, NEUROSCI RES CTR, HARLOW CM20 2QR, ESSEX, ENGLAND
来源：
BEHAVIOURAL BRAIN RESEARCH | 1996年 / 73卷 / 1-2期
关键词：
5-HT; dopamine; receptor subtype; mesolimbic; clozapine; schizophrenia;
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
Many neurochemical, electrophysiological and behavioural studies have shown how 5-HT and dopamine neuronal systems are able to interact and it is highly likely that the therapeutic benefits of clozapine-like atypical antipsychotic drugs are achieved by the modulation of such interactions. There are, however, at least fourteen subtypes of 5-HT receptor and five subtypes of dopamine receptor expressed in rodent and/or human brain and the optimum combination of receptor affinities required for maximum therapeutic benefit remains enigmatic.
引用
收藏
页码：15 / 17
页数：3
相关论文
共 50 条
  • [21] Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    Reubi, JC
    Waser, B
    Schaer, JC
    Laissue, JA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (07) : 836 - 846
  • [22] It might be a big family but the pain remains-last chance saloon for selective 5-HT receptor ligands?
    Andrews, Nick
    O'Neill, Michael F.
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (01) : 39 - 44
  • [23] Interactions of Serotonin (5-HT)2 Receptor-Targeting Ligands and Nicotine: Locomotor Activity Studies in Rats
    Zaniewska, Magdalena
    McCreary, Andrew C.
    Filip, Malgorzata
    SYNAPSE, 2009, 63 (08) : 653 - 661
  • [24] Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands:: Potent, TRβ subtype-selective thyromimetics
    Dow, RL
    Schneider, SR
    Paight, ES
    Hank, RF
    Chiang, P
    Cornelius, P
    Lee, E
    Newsome, WP
    Swick, AG
    Spitzer, J
    Hargrove, DM
    Patterson, TA
    Pandit, J
    Chrunyk, BA
    LeMotte, PK
    Danley, DE
    Rosner, MH
    Ammirati, MJ
    Simons, SP
    Schulte, GK
    Tate, BF
    DaSilva-Jardine, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 379 - 382
  • [25] Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    Jean Reubi
    Beatrice Waser
    Jean-Claude Schaer
    Jean A. Laissue
    European Journal of Nuclear Medicine, 2001, 28 : 836 - 846
  • [26] Potential vascular alphal1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat
    Sanchez-Lopez, A.
    Centurion, D.
    Lozano-Cuenca, J.
    Albarran-Juarez, J. A.
    Monroy-Ordonez, E. B.
    Cobos-Puc, L. E.
    Villalon, C. M.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 78 - 78
  • [27] Bifeprunox: a novel atypical antipsychotic sharing dopamine D(2,3,4) receptor and serotonin 5-HT(1A) receptor affinities
    Marquis, K
    Hertel, P
    Reinders, JH
    Van der Neut, M
    Ronken, E
    McCreary, AC
    Herremans, AHJ
    Hesselink, MB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S487 - S487
  • [28] SC-53116 - THE 1ST SELECTIVE AGONIST AT THE NEWLY IDENTIFIED SEROTONIN 5-HT(4) RECEPTOR SUBTYPE
    FLYNN, DL
    ZABROWSKI, DL
    BECKER, DP
    NOSAL, R
    VILLAMIL, CI
    GULLIKSON, GW
    MOUMMI, C
    YANG, DC
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) : 1486 - 1489
  • [29] Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
    Mallo-Abreu, Ana
    Reyes-Resina, Irene
    Azuaje, Jhonny
    Franco, Rafael
    Garcia-Rey, Aitor
    Majellaro, Maria
    Miranda-Pastoriza, Dario
    Garcia-Mera, Xerardo
    Jespers, Willem
    Gutierrez-de-Teran, Hugo
    Navarro, Gemma
    Sotelo, Eddy
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) : 8710 - 8726
  • [30] Syntheses and radiofluorination of two derivatives of 5-cyano-indole as selective ligands for the dopamine subtype-4 receptor
    Tietze, R
    Hocke, C
    Löber, S
    Hübner, H
    Kuwert, T
    Gmeiner, P
    Prante, O
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (01): : 55 - 70
12345